|
|
||||||||
From the Department of Neurology, New York University School of Medicine, New York, NY.
Supported in part by the Margaret Enoch fundG. is recipient of the H.I. Duggan Investigator Award from the Arthritis Foundation. S.B. is recipient of a fellowship from the Human Frontier Science Program Organization (HFSPO).
Received August 16, 1995. Accepted in final form December 4, 1995.
Address correspondence and reprint requests to Dr. E.H. Kolodny, Department of Neurology, New York University School of Medicine, 550 First Avenue, New York, NY 10016.
Late-onset GM2 gangliosidosis is a variant form of Tay-Sachs disease characterized by onset of symptoms and signs in adolescence or in early adult life. The deficiency of beta-hexosaminidase A (Hex A) in this form of GM2 gangliosidosis has been invariably associated with the presence of the Gly269 right arrow Ser substitution in the alpha-chain. We found two siblings of Ashkenazi Jewish descent diagnosed with late-onset GM2 gangliosidosis who were negative for the Gly269 right arrow Ser mutation. Analysis of the HEXA gene showed that they were compound heterozygotes for the functionally silent 4-bp insertion in exon 11, typical of the infantile form of the disease and for a novel mutation, T538 right arrow C, resulting in the missense Tyr180 right arrow His. Expression studies in COS-7 cells suggested that the effect of this mutation was to decrease the stability of the alpha-chain at physiologic temperatures and therefore to indirectly affect the formation of mature Hex A.
NEUROLOGY 1996;47: 547-552
This article has been cited by other articles:
![]() |
G. H. B. Maegawa, T. Stockley, M. Tropak, B. Banwell, S. Blaser, F. Kok, R. Giugliani, D. Mahuran, and J. T.R. Clarke The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously Reported Pediatrics, November 1, 2006; 118(5): e1550 - e1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Frey, S. P. Ringel, and C. M. Filley The Natural History of Cognitive Dysfunction in Late-Onset GM2 Gangliosidosis Arch Neurol, June 1, 2005; 62(6): 989 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Rucker, B. E. Shapiro, Y. H. Han, A. N. Kumar, S. Garbutt, E. L. Keller, and R. J. Leigh Neuro-ophthalmology of late-onset Tay-Sachs disease (LOTS) Neurology, November 23, 2004; 63(10): 1918 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Tropak, S. P. Reid, M. Guiral, S. G. Withers, and D. Mahuran Pharmacological Enhancement of {beta}-Hexosaminidase Activity in Fibroblasts from Adult Tay-Sachs and Sandhoff Patients J. Biol. Chem., April 2, 2004; 279(14): 13478 - 13487. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Nassogne, M.-C. Commare, A. Lellouch-Tubiana, S. Emond, M. Zerah, C. Caillaud, L. Hertz-Pannier, and J.-M. Saudubray Unusual Presentation of GM2 Gangliosidosis Mimicking a Brain Stem Tumor in a 3-Year-Old Girl AJNR Am. J. Neuroradiol., May 1, 2003; 24(5): 840 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hou, B. McInnes, A. Hinek, G. Karpati, and D. Mahuran A Pro504 right-arrow Ser Substitution in the beta -Subunit of beta -Hexosaminidase A Inhibits alpha -Subunit Hydrolysis of GM2 Ganglioside, Resulting in Chronic Sandhoff Disease J. Biol. Chem., August 14, 1998; 273(33): 21386 - 21392. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |